Prognosis, Decisions, and Quality of Life
Published: | Updated:
At a Glance
The prognosis for holoprosencephaly (HPE) depends heavily on its severity. Severe forms like alobar HPE have a very short life expectancy, while children with milder forms can live into adulthood. Care focuses on managing complications and maximizing the child's comfort and quality of life.
Key Takeaways
- • Prognosis for holoprosencephaly varies widely and is primarily determined by the severity of the brain malformation.
- • Babies with the severe alobar subtype usually have a very limited life expectancy and require intensive medical intervention.
- • Children with milder forms often survive into childhood or adulthood but face significant developmental and motor delays.
- • Managing feeding issues, respiratory problems, and endocrine stability is essential for extending survival and improving a child's quality of life.
- • Palliative care offers crucial support by prioritizing a child's comfort, managing symptoms, and providing emotional guidance for families.
Facing the future after a diagnosis of Holoprosencephaly (HPE) requires a delicate balance of honesty and hope. Because HPE is a spectrum, there is no single “typical” outcome. Instead, prognosis is deeply tied to the specific subtype of the condition and the presence of other medical complications [1][2].
Prenatal Decision-Making
For many families, an HPE diagnosis occurs during a prenatal ultrasound. Because the most severe forms of HPE (like alobar) have an extremely poor prognosis, parents are often faced with agonizing choices immediately following the diagnosis [3].
Depending on your beliefs, local laws, and the medical severity, you may need to discuss options with your team, including:
- Continuing the pregnancy with a plan for aggressive medical intervention after birth.
- Perinatal Hospice: Continuing the pregnancy while focusing entirely on a peaceful birth, bonding, and comfort care (palliative care) for the baby.
- Termination of the pregnancy for medical reasons.
There is no “right” choice—only the choice that is most compassionate for your child and your family. Your medical team and genetic counselors are there to support you without judgment.
Survival and the HPE Subtypes
For babies born with HPE, the most significant factor in their prognosis is the degree of brain malformation [1].
- Alobar HPE: This is the most severe form. Historically, it has been described as incompatible with life, and many fetuses with alobar HPE result in miscarriage or stillbirth [3][4]. Infants born with alobar HPE often have a very limited life expectancy, frequently measured in days or months [5][4]. While some children do survive into infancy and beyond with intensive medical management, it is crucial to know that this survival is exceptionally rare and highly medicalized (often requiring life support systems and profound intervention) [6][7].
- Non-Alobar HPE (Semilobar, Lobar, MIHV): These subtypes have a much more variable prognosis. Many children with these forms survive into childhood and even adulthood [2][8]. While they face significant medical and developmental challenges, their life expectancy is often much longer than those with the alobar form [2].
Neurodevelopmental Outcomes and Daily Life
For children who survive the initial newborn period with milder forms of HPE, neurodevelopmental outcomes vary widely based on the brain’s structure [2][9].
- Motor and Cognitive Delays: Most children with HPE will experience significant delays in hitting milestones like sitting, crawling, and walking [2][8]. Cognitive development is also impacted, with many children requiring specialized educational and therapeutic support (Physical, Occupational, and Speech therapies) built into their daily lives [2].
- Communication: While some children may develop limited verbal language, many use non-verbal methods (like assistive communication devices) to communicate their needs and bond with their families [2].
Factors Influencing Quality of Life
A child’s quality of life and overall survival are often determined by how well their secondary medical complications are managed [10].
- Respiratory and Feeding Issues: Difficulty swallowing (dysphagia) can lead to aspiration (inhaling food or liquid), which increases the risk of pneumonia—a major cause of illness in children with HPE [11][5].
- Endocrine Stability and Temperature: Issues like Central Diabetes Insipidus or other hormone deficiencies can be life-threatening if not carefully monitored. Additionally, hypothalamic dysfunction often causes dangerous body temperature swings, requiring vigilant monitoring from parents [12][13].
- Systemic Anomalies: Children with HPE may also have congenital heart defects or kidney issues. The presence of these extra-cranial problems can significantly complicate their care and affect their prognosis [14][15].
The Role of Palliative Care
For many families, especially those with a child diagnosed with a severe form of HPE, the focus of care shifts to Palliative Care. This is not “giving up”; rather, it is a specialized medical approach focused on:
- Maximizing Comfort: Managing pain, secretions, and seizures to ensure the child is peaceful [16].
- Quality of Life: Prioritizing the child’s ability to interact with their family and participate in meaningful experiences [16].
- Family Support: Providing emotional, spiritual, and logistical support for parents and siblings during a deeply difficult time [16].
Every child’s journey with HPE is unique. Your medical team will work with you to understand your child’s specific needs and help you make decisions that align with your family’s values and your child’s comfort [17][18].
Frequently Asked Questions
What is the life expectancy for a baby with alobar HPE?
Can a child survive with milder forms of holoprosencephaly?
What therapies are helpful for a child with HPE?
What is perinatal hospice for an HPE diagnosis?
Why do children with HPE need their temperature monitored closely?
Questions for Your Doctor
- • Based on our child's specific subtype, what is the realistic expectation for their life expectancy?
- • If diagnosed prenatally, what are our options for perinatal hospice and palliative care?
- • What are the most likely neurodevelopmental milestones our child might reach, and what therapies will help them?
- • How will we monitor for the major complications that impact survival, like respiratory issues or endocrine failure?
- • Can you connect us with a palliative care team to help us focus on our child's comfort and quality of life right now?
Questions for You
- • What does 'quality of life' mean to our family, and how can we prioritize that for our child?
- • How am I feeling about the balance between medical interventions and our child's day-to-day comfort?
- • Who can I talk to about the grief and agonizing choices I am facing right now?
Want personalized information?
Type your question below to get evidence-based answers tailored to your situation.
References
- 1
Are the prevalence of Trisomy 13 and the incidence of severe holoprosencephaly increasing in Africa?
Okoye JO, Ngokere AA
Prenatal diagnosis 2020; (40(12)):1616-1617 doi:10.1002/pd.5777.
PMID: 32715507 - 2
In-depth investigations of adolescents and adults with holoprosencephaly identify unique characteristics.
Weiss K, Kruszka P, Guillen Sacoto MJ, et al.
Genetics in medicine : official journal of the American College of Medical Genetics 2018; (20(1)):14-23 doi:10.1038/gim.2017.68.
PMID: 28640243 - 3
Alobar holoprosencephaly with cebocephaly in a neonate: A rare case report from Northern Tanzania.
Ariyo IJ, Mchaile DN, Magwizi M, et al.
International journal of surgery case reports 2022; (93()):106960 doi:10.1016/j.ijscr.2022.106960.
PMID: 35364389 - 4
Alobar Holoprosencephaly Associated with Meningomyelocoele and Omphalocoele: An Unusual Coexistence.
Waghmare TP, Sathe PA, Goel NA, Kandalkar BM
Journal of clinical and diagnostic research : JCDR 2016; (10(11)):ED23-ED24 doi:10.7860/JCDR/2016/22453.8932.
PMID: 28050387 - 5
Alobar Holoprosencephaly with Cebocephaly in a Neonate Born to an HIV-Positive Mother in Eastern Uganda.
Sikakulya FK, Kiyaka SM, Masereka R, Ssebuufu R
Case reports in otolaryngology 2021; (2021()):7282283 doi:10.1155/2021/7282283.
PMID: 34733564 - 6
Congenital complete arhinia with alobar holoprosencephaly.
Boakye-Yiadom AP, Nguah SB, Mahama H, Plange-Rhule G
Ghana medical journal 2022; (56(3)):231-235 doi:10.4314/gmj.v56i3.14.
PMID: 37449001 - 7
Surgical Nuances in Ultrasound-Guided Percutaneous Distal Catheter Placement in Pediatric Ventriculoatrial Shunts.
Reynoso LG, Rodríguez Lezama A, Hernández Martínez CA, et al.
Cureus 2025; (17(5)):e84345 doi:10.7759/cureus.84345.
PMID: 40535372 - 8
Lobar holoprosencephaly with associated meningocele: A rare case report of a 25-year-old patient with multiple seizures.
Barman P, Mishra GV, Murugan G, et al.
Radiology case reports 2025; (20(4)):2004-2008 doi:10.1016/j.radcr.2025.01.029.
PMID: 39963386 - 9
Holoprosencephaly: Review of Embryology, Clinical Phenotypes, Etiology and Management.
Malta M, AlMutiri R, Martin CS, Srour M
Children (Basel, Switzerland) 2023; (10(4)) doi:10.3390/children10040647.
PMID: 37189898 - 10
Identifying environmental risk factors and gene-environment interactions in holoprosencephaly.
Addissie YA, Troia A, Wong ZC, et al.
Birth defects research 2021; (113(1)):63-76 doi:10.1002/bdr2.1834.
PMID: 33111505 - 11
Use of an Orthodontic and Otolaryngological Approach in an Infant with Holoprosencephaly.
Galeotti A, De Vincentiis GC, Sitzia E, et al.
Children (Basel, Switzerland) 2024; (11(5)) doi:10.3390/children11050554.
PMID: 38790549 - 12
Intravenous formulation of desmopressin delivered via oral and g tube routes for the treatment of central diabetes insipidus: First experience in infants.
Lim WY, Riba-Wolman R
Clinical endocrinology 2020; (92(2)):179-181 doi:10.1111/cen.14125.
PMID: 31715009 - 13
Sublingual Administration of Desmopressin Oral Disintegrating Tablet in a Neonate With Central Diabetes Insipidus.
Watanabe D, Yagasaki H, Tsukahara M, et al.
Cureus 2025; (17(7)):e87902 doi:10.7759/cureus.87902.
PMID: 40809652 - 14
Comorbidity of congenital heart defects and holoprosencephaly is likely genetically driven and gene-specific.
Tekendo-Ngongang C, Owosela B, Muenke M, Kruszka P
American journal of medical genetics. Part C, Seminars in medical genetics 2020; (184(1)):154-158 doi:10.1002/ajmg.c.31770.
PMID: 32022405 - 15
Case Report: An Infant With Kabuki Syndrome, Alobar Holoprosencephaly and Truncus Arteriosus: A Case for Whole Exome Sequencing in Neonates With Congenital Anomalies.
Sakaria RP, Zaveri PG, Holtrop S, et al.
Frontiers in genetics 2021; (12()):766316 doi:10.3389/fgene.2021.766316.
PMID: 34899850 - 16
Challenging issues arising in counseling families experiencing holoprosencephaly.
Hadley DW, Kruszka P, Muenke M
American journal of medical genetics. Part C, Seminars in medical genetics 2018; (178(2)):238-245 doi:10.1002/ajmg.c.31627.
PMID: 30182441 - 17
Antenatal Ultrasonographic Diagnosis of a Constellation of Alobar Holoprosencephaly, Ethmocephaly, and Hydronephrosis in a Case of Early-Onset Intrauterine Growth Retardation: A Case Report.
Ghanta PR, Phatak S, Bhansali PJ, et al.
Cureus 2022; (14(7)):e27375 doi:10.7759/cureus.27375.
PMID: 36046320 - 18
Prenatal imaging diagnosis of iniencephaly apertus associated with heterotaxy syndrome, alobar holoprosencephaly and myelomeningocele: a case report.
Minchola-Vega JL, Zamora-Mostacero VE, Lazarte-Rantes CI
AJOG global reports 2025; (5(3)):100539 doi:10.1016/j.xagr.2025.100539.
PMID: 40740247
This page provides general information about holoprosencephaly prognosis and care options for educational purposes. Always discuss your child's specific diagnosis, life expectancy, and care plan with your medical team.
Stay up to date
Get notified when new research about Holoprosencephaly is published.
No spam. Unsubscribe anytime.